← Back to home

SEVERE SYMPTOMATIC AORTIC STENOSIS (DEFINED AS NEW YORK HEART ASSOCIATION (NYHA) CLASS ≥ II)

Clinical trials for SEVERE SYMPTOMATIC AORTIC STENOSIS (DEFINED AS NEW YORK HEART ASSOCIATION (NYHA) CLASS ≥ II) explained in plain language.

Never miss a new study

Get alerted when new SEVERE SYMPTOMATIC AORTIC STENOSIS (DEFINED AS NEW YORK HEART ASSOCIATION (NYHA) CLASS ≥ II) trials appear

Sign up with your email to follow new studies for SEVERE SYMPTOMATIC AORTIC STENOSIS (DEFINED AS NEW YORK HEART ASSOCIATION (NYHA) CLASS ≥ II), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Portuguese hospitals track new heart valve procedure for 500 patients

Disease control Not yet recruiting

This registry study aims to track how well a specific heart valve replacement device works for adults with severe aortic valve narrowing. Researchers will follow 500 patients at 12 Portuguese hospitals for one year to see if using a standardized procedure improves safety and outc…

Matched conditions: SEVERE SYMPTOMATIC AORTIC STENOSIS (DEFINED AS NEW YORK HEART ASSOCIATION (NYHA) CLASS ≥ II)

Sponsor: Portuguese Association of Interventional Cardiology • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

SEVERE SYMPTOMATIC AORTIC STENOSIS (DEFINED AS NEW YORK HEART ASSOCIATION (NYHA) CLASS ≥ II)

Get alerted when new SEVERE SYMPTOMATIC AORTIC STENOSIS (DEFINED AS NEW YORK HEART ASSOCIATION (NYHA) CLASS ≥ II) trials appear

Portuguese hospitals track new heart valve procedure for 500 patients